CDEK
← All organizations

Dendreon

For profitContributed to NME

Also known as: Dendreon | Dendreon Corp. | Dendreon Pharmaceuticals LLC

Phase 1Phase 2Phase 3Phase 4

Highest phase reached

Phase 3

First clinical trial

Nov 1, 1999

First marketed drug

Apr 29, 2010

First NDA

Apr 29, 2010

Last known activity

Nov 30, 2023

Acquired by Bausch Health Companies on Feb 23, 2015

Timeline

1990s

  1. Jul 1, 1992

    Dendreon— Founded

2010s

  1. Apr 29, 2010

    sipuleucel-t— NDA Organization

  2. Feb 23, 2015

    Bausch Health Companies— Acquired By

Drugs by trial phase (9 distinct, 23 trials)

Phase 3 (1 own, 0 via acquisition)

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Marketed drugs (1)

Recent trials (26)

Details

Founded
Seattle, WA, US Jul 1, 1992
First NDA
Apr 29, 2010
Last known activity
Nov 30, 2023

Notes

Acquired by Valeant